Tag

Neurodegeneration

All articles tagged with #neurodegeneration

Retinal Chlamydia pneumoniae Tied to Faster Alzheimer’s Progression
science8 days ago

Retinal Chlamydia pneumoniae Tied to Faster Alzheimer’s Progression

A Cedars-Sinai study found the pneumonia-causing bacterium Chlamydia pneumoniae in the retina, with higher bacterial loads in individuals with Alzheimer’s disease; the bacteria may amplify brain pathology by triggering the NLRP3 inflammasome, increasing inflammation and amyloid beta, and the retina could serve as a noninvasive biomarker for disease status while anti-inflammatory or antibiotic strategies are being explored, though questions remain about how and when infection occurs.

Air Pollution May Directly Accelerate Alzheimer's Risk, Study Finds
science8 days ago

Air Pollution May Directly Accelerate Alzheimer's Risk, Study Finds

A large observational study from Emory University analyzing about 27.8 million US seniors over 18 years links higher 5-year average PM2.5 exposure to increased Alzheimer's disease risk, suggesting direct brain effects beyond traditional risk factors. Using ZIP-code pollution estimates, the researchers found a strong association even after adjusting for comorbidities, with stroke appearing to heighten vulnerability. While causality can’t be proven, the findings support the public health case for reducing air pollution to help lower dementia risk.

Late-Life Depression Linked to Early Parkinson's or Lewy Body Dementia, Study Finds
health9 days ago

Late-Life Depression Linked to Early Parkinson's or Lewy Body Dementia, Study Finds

A Danish study following 17,711 people over 12 years found that depression is more common years before a diagnosis of Parkinson's disease or Lewy body dementia, with rates rising about eight years prior and remaining elevated after diagnosis, strongest for Lewy body dementia. By comparing with rheumatoid arthritis, chronic kidney disease, and osteoporosis, researchers suggest the link isn’t solely due to disability. The study shows association, not causation, and supports screening older adults with new or late-onset depression for early neurodegenerative signs to enable earlier care and research.

Neuron-type aging clocks map vulnerability and unveil neuroprotective drug candidates
science22 days ago

Neuron-type aging clocks map vulnerability and unveil neuroprotective drug candidates

Aging clocks applied to single neuron types in C. elegans reveal neuron-type–specific biological ages, with environmentally exposed ciliated amphid neurons aging fastest and degenerating earlier. Reducing translation slows degeneration in fast-aging neurons, and neuronal aging patterns correlate with human brain aging while anticorrelating with known geroprotective interventions. An in silico CMAP screen identifies potential neuroprotective compounds, notably syringic acid and vanoxerine, while some agents (e.g., WAY-100635, Bay K8644) can be neurotoxic. The study suggests neuron-type aging trajectories can guide protective interventions and risk-factor identification for neurodegeneration across species.

OTULIN: A Master Switch for Tau Points to a New Alzheimer’s Target
science29 days ago

OTULIN: A Master Switch for Tau Points to a New Alzheimer’s Target

Researchers show the enzyme OTULIN acts as a master regulator of tau production in neurons: blocking OTULIN reduced tau levels and removing its gene even halted tau synthesis, while RNA analysis revealed widespread changes in gene activity, notably in inflammatory pathways; the findings open a potential new route to slow brain aging and Alzheimer's, but safety concerns remain since OTULIN and tau have essential functions and much more research is needed.

Mice Reversal of Advanced Alzheimer's Sparks Hope for Humans
health1 month ago

Mice Reversal of Advanced Alzheimer's Sparks Hope for Humans

A study from University Hospitals, Case Western Reserve University, and the Cleveland VA reversed advanced Alzheimer's in mice by stabilizing brain NAD+ energy balance with the compound P7C3-A20, achieving full cognitive recovery and suggesting a potential amyloid-independent therapy for humans. While promising, results in animals don’t guarantee human success; the team aims for phase I safety trials within about 18 months and envisions broader use for neurodegeneration, alongside lifestyle measures and caregiver support.

health1 month ago

NAD+ Boost Could Rewind Alzheimer’s Signs in Mice, Early Study Says

A Cell Reports Medicine study in two Alzheimer’s mouse models shows that restoring NAD+ balance can reverse key disease features and restore memory, with human brain tissue from severe cases showing similar NAD+ disruptions. While not a human trial and NAD+-targeted therapies aren’t approved, the findings suggest Alzheimer’s progression may stem from reversible cellular energy/repair failures and highlight NAD+ as a promising upstream target and lifestyle factor to support brain resilience.

Promising Gene Therapy Hints at Slowing Huntington's Disease Progression
science1 month ago

Promising Gene Therapy Hints at Slowing Huntington's Disease Progression

A small trial of uniQure’s AMT-130 gene therapy in 29 Huntington’s disease patients showed reduced production of the mutant huntingtin protein, slower cognitive decline, and lower levels of neurofilament light in cerebrospinal fluid over three years, suggesting a potential disease-modifying effect. Results were reported in a press release and have not yet undergone peer review, but they point to a possible treatment that could be used earlier in the disease course, while researchers continue to identify early biomarkers and expand the treatment window before motor symptoms appear.

Chlorpyrifos Exposure Linked to Substantially Higher Parkinson’s Risk
science1 month ago

Chlorpyrifos Exposure Linked to Substantially Higher Parkinson’s Risk

A UCLA Health study links long-term residential exposure to the pesticide chlorpyrifos with more than a 2.5-fold increase in Parkinson’s disease risk. Animal tests show chlorpyrifos damages dopamine neurons and triggers brain inflammation via autophagy disruption, suggesting autophagy restoration as a potential therapeutic angle. Despite declines in the U.S., past exposure and ongoing use elsewhere mean monitoring and further research on pesticide-related neurodegeneration are warranted.